SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001297184-24-000042
Filing Date
2024-06-04
Accepted
2024-06-04 16:14:52
Documents
15
Period of Report
2024-06-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amph-20240603x8k.htm   iXBRL 8-K 76717
2 EX-10.1 amph-20240603xex10d1.htm EX-10.1 155352
3 EX-99.1 amph-20240603xex99d1.htm EX-99.1 14308
  Complete submission text file 0001297184-24-000042.txt   401884

Data Files

Seq Description Document Type Size
4 EX-101.SCH amph-20240603.xsd EX-101.SCH 3361
5 EX-101.LAB amph-20240603_lab.xml EX-101.LAB 15359
6 EX-101.PRE amph-20240603_pre.xml EX-101.PRE 10383
18 EXTRACTED XBRL INSTANCE DOCUMENT amph-20240603x8k_htm.xml XML 4643
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 241018191
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)